OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.
| Website | https://www.orsobio.com |
| Employees | 19 (12 on RocketReach) |
| Founded | 2021 |
| Phone | +1 954-927-2044 |
| Industry | Biotechnology Research |
| Keywords | Metabolic Disorders, Biopharmaceutical, Clinical Stage, Therapeutic Development, Pharmaceutical Research, Drug Development, Type 2 Diabetes Treatment, Biotechnology, Drug Discovery, Endocrine Disorders, Nash Treatment, Clinical Trials, Innovative Therapies, Hepatic Disease, Lipid Disorders, New Medicines, Rare Diseases |
| Competitors | Novartis, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Genentech, Amgen, Regeneron, Biogen, Lilly India +45 more (view full list) |
Looking for a particular OrsoBio employee's phone or email?
OrsoBio Questions
G. Subramanian is the CEO of OrsoBio.
12 people are employed at OrsoBio.
OrsoBio is based in Palo Alto, California.
Top OrsoBio Employees
-
G. Subramanian
CEO at OrsoBio
California, United States1 -
Ryan Huss
SVP, Clinical Development and Operations at OrsoBio
Palo Alto, CA, US35 -
Steve Weng
Senior Vice President Product Development and Program Management at OrsoBio
California, United States23 -
25+
-
Gans Ganapati
Chief Financial Officer at OrsoBio
Menlo Park, CA, US1 -
Monika Sharma
Director at OrsoBio
California, United States15 -
Sam Zenhari
Senior Director Clinical Operations at OrsoBio
San Francisco, CA, US12 -
Archana Vijayakumar
Director, Research Biology at OrsoBio
San Mateo, CA, US11 -
Alex Nguyen
Vice President Finance and Controller at OrsoBio
Raleigh, NC, US55+
Related Companies
G2Crowd Trusted
300K+
Plugin Users
